vs
CITIUS ONCOLOGY, INC.(CTOR)与PureCycle Technologies, Inc.(PCT)财务数据对比。点击上方公司名可切换其他公司
CITIUS ONCOLOGY, INC.的季度营收约是PureCycle Technologies, Inc.的1.5倍($3.9M vs $2.7M),CITIUS ONCOLOGY, INC.净利率更高(-140.3% vs -697.1%,领先556.8%)
Citius Oncology是一家处于后期阶段的生物制药企业,专注于开发针对癌症患者的创新靶向疗法,核心管线覆盖血液恶性肿瘤和实体瘤领域的未满足医疗需求,主要服务北美及全球肿瘤诊疗市场。
PureCycle Technologies是一家可持续材料企业,持有专利聚丙烯先进回收技术,可将受污染的聚丙烯废料转化为高纯度、与原生品质相当的聚丙烯树脂,产品广泛应用于消费品、汽车零部件、包装及工业领域,服务全球合作伙伴。
CTOR vs PCT — 直观对比
营收规模更大
CTOR
是对方的1.5倍
$2.7M
净利率更高
CTOR
高出556.8%
-697.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $3.9M | $2.7M |
| 净利润 | $-5.5M | $-18.8M |
| 毛利率 | 80.0% | — |
| 营业利润率 | -133.2% | -2196.1% |
| 净利率 | -140.3% | -697.1% |
| 营收同比 | — | — |
| 净利润同比 | 16.9% | 71.0% |
| 每股收益(稀释后) | $-0.06 | $-0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTOR
PCT
| Q4 25 | $3.9M | $2.7M | ||
| Q3 25 | — | $2.4M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $1.6M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
净利润
CTOR
PCT
| Q4 25 | $-5.5M | $-18.8M | ||
| Q3 25 | — | $-28.4M | ||
| Q2 25 | — | $-144.2M | ||
| Q1 25 | — | $8.8M | ||
| Q4 24 | — | $-64.7M | ||
| Q3 24 | — | $-90.6M | ||
| Q2 24 | — | $-48.2M | ||
| Q1 24 | — | $-85.6M |
毛利率
CTOR
PCT
| Q4 25 | 80.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
CTOR
PCT
| Q4 25 | -133.2% | -2196.1% | ||
| Q3 25 | — | -1602.2% | ||
| Q2 25 | — | -2763.5% | ||
| Q1 25 | — | -2387.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
净利率
CTOR
PCT
| Q4 25 | -140.3% | -697.1% | ||
| Q3 25 | — | -1167.5% | ||
| Q2 25 | — | -8741.8% | ||
| Q1 25 | — | 559.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
每股收益(稀释后)
CTOR
PCT
| Q4 25 | $-0.06 | $-0.14 | ||
| Q3 25 | — | $-0.31 | ||
| Q2 25 | — | $-0.81 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $-0.40 | ||
| Q3 24 | — | $-0.54 | ||
| Q2 24 | — | $-0.29 | ||
| Q1 24 | — | $-0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $7.3M | $156.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $58.4M | $45.9M |
| 总资产 | $110.0M | $922.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CTOR
PCT
| Q4 25 | $7.3M | $156.7M | ||
| Q3 25 | — | $234.4M | ||
| Q2 25 | — | $284.1M | ||
| Q1 25 | — | $22.5M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $83.7M | ||
| Q2 24 | — | $10.9M | ||
| Q1 24 | — | $25.0M |
股东权益
CTOR
PCT
| Q4 25 | $58.4M | $45.9M | ||
| Q3 25 | — | $68.2M | ||
| Q2 25 | — | $98.9M | ||
| Q1 25 | — | $238.2M | ||
| Q4 24 | — | $180.4M | ||
| Q3 24 | — | $241.4M | ||
| Q2 24 | — | $291.6M | ||
| Q1 24 | — | $336.8M |
总资产
CTOR
PCT
| Q4 25 | $110.0M | $922.7M | ||
| Q3 25 | — | $989.1M | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $787.3M | ||
| Q4 24 | — | $798.4M | ||
| Q3 24 | — | $788.8M | ||
| Q2 24 | — | $719.8M | ||
| Q1 24 | — | $734.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-7.4M | $-28.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-42.0M |
| 自由现金流率自由现金流/营收 | — | -1559.6% |
| 资本支出强度资本支出/营收 | — | 495.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-183.6M |
8季度趋势,按日历期对齐
经营现金流
CTOR
PCT
| Q4 25 | $-7.4M | $-28.7M | ||
| Q3 25 | — | $-38.5M | ||
| Q2 25 | — | $-36.7M | ||
| Q1 25 | — | $-38.9M | ||
| Q4 24 | — | $-31.8M | ||
| Q3 24 | — | $-33.4M | ||
| Q2 24 | — | $-40.4M | ||
| Q1 24 | — | $-39.2M |
自由现金流
CTOR
PCT
| Q4 25 | — | $-42.0M | ||
| Q3 25 | — | $-42.4M | ||
| Q2 25 | — | $-45.3M | ||
| Q1 25 | — | $-53.9M | ||
| Q4 24 | — | $-53.4M | ||
| Q3 24 | — | $-42.6M | ||
| Q2 24 | — | $-50.8M | ||
| Q1 24 | — | $-53.5M |
自由现金流率
CTOR
PCT
| Q4 25 | — | -1559.6% | ||
| Q3 25 | — | -1743.1% | ||
| Q2 25 | — | -2747.1% | ||
| Q1 25 | — | -3409.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
CTOR
PCT
| Q4 25 | — | 495.1% | ||
| Q3 25 | — | 160.3% | ||
| Q2 25 | — | 521.5% | ||
| Q1 25 | — | 949.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
CTOR
PCT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.40× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图